FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090912504> ?p ?o ?g. }

• W2090912504 abstract "Abstract Background Imatinib represents the first in a class of drugs targeted against chronic myelogenous leukemia to enter the clinic, showing excellent efficacy and specificity for Abl, Kit, and PDGFR kinases. Recent screens carried out to find off-target proteins that bind to imatinib identified the oxidoreductase NQO2, a flavoprotein that is phosphorylated in a chronic myelogenous leukemia cell line. Results We examined the inhibition of NQO2 activity by the Abl kinase inhibitors imatinib, nilotinib, and dasatinib, and obtained IC 50 values of 80 nM, 380 nM, and >100 μM, respectively. Using electronic absorption spectroscopy, we show that imatinib binding results in a perturbation of the protein environment around the flavin prosthetic group in NQO2. We have determined the crystal structure of the complex of imatinib with human NQO2 at 1.75 Å resolution, which reveals that imatinib binds in the enzyme active site, adjacent to the flavin isoalloxazine ring. We find that phosphorylation of NQO2 has little effect on enzyme activity and is therefore likely to regulate other aspects of NQO2 function. Conclusion The structure of the imatinib-NQO2 complex demonstrates that imatinib inhibits NQO2 activity by competing with substrate for the active site. The overall conformation of imatinib when bound to NQO2 resembles the folded conformation observed in some kinase complexes. Interactions made by imatinib with residues at the rim of the active site provide an explanation for the binding selectivity of NQO2 for imatinib, nilotinib, and dasatinib. These interactions also provide a rationale for the lack of inhibition of the related oxidoreductase NQO1 by these compounds. Taken together, these studies provide insight into the mechanism of NQO2 inhibition by imatinib, with potential implications for drug design and treatment of chronic myelogenous leukemia in patients." @default.
• W2090912504 created "2016-06-24" @default.
• W2090912504 creator A5008651904 @default.
• W2090912504 creator A5033050158 @default.
• W2090912504 creator A5038330393 @default.
• W2090912504 creator A5069216326 @default.
• W2090912504 date "2009-02-24" @default.
• W2090912504 modified "2023-10-16" @default.
• W2090912504 title "The structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2)" @default.
• W2090912504 cites W1520730837 @default.
• W2090912504 cites W1964358866 @default.
• W2090912504 cites W1967532400 @default.
• W2090912504 cites W1979092710 @default.
• W2090912504 cites W1983457087 @default.
• W2090912504 cites W1984685395 @default.
• W2090912504 cites W1986139301 @default.
• W2090912504 cites W1986851225 @default.
• W2090912504 cites W1994286350 @default.
• W2090912504 cites W1995367007 @default.
• W2090912504 cites W1996607909 @default.
• W2090912504 cites W1999614615 @default.
• W2090912504 cites W2001641653 @default.
• W2090912504 cites W2003894821 @default.
• W2090912504 cites W2003973314 @default.
• W2090912504 cites W2006917576 @default.
• W2090912504 cites W2012238745 @default.
• W2090912504 cites W2015015957 @default.
• W2090912504 cites W2015616444 @default.
• W2090912504 cites W2016055538 @default.
• W2090912504 cites W2025132816 @default.
• W2090912504 cites W2026542427 @default.
• W2090912504 cites W2034862875 @default.
• W2090912504 cites W2040396943 @default.
• W2090912504 cites W2041415161 @default.
• W2090912504 cites W2045195164 @default.
• W2090912504 cites W2048633418 @default.
• W2090912504 cites W2051064724 @default.
• W2090912504 cites W2054251966 @default.
• W2090912504 cites W2057468615 @default.
• W2090912504 cites W2057761407 @default.
• W2090912504 cites W2064698668 @default.
• W2090912504 cites W2069207813 @default.
• W2090912504 cites W2090004346 @default.
• W2090912504 cites W2094294128 @default.
• W2090912504 cites W2107268345 @default.
• W2090912504 cites W2109184569 @default.
• W2090912504 cites W2124196948 @default.
• W2090912504 cites W2131174104 @default.
• W2090912504 cites W2131473290 @default.
• W2090912504 cites W2144081223 @default.
• W2090912504 cites W2146928870 @default.
• W2090912504 cites W2161835431 @default.
• W2090912504 cites W2162658917 @default.
• W2090912504 cites W2312804644 @default.
• W2090912504 cites W2329648702 @default.
• W2090912504 cites W25878943 @default.
• W2090912504 cites W294420646 @default.
• W2090912504 doi "https://doi.org/10.1186/1472-6807-9-7" @default.
• W2090912504 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2655291" @default.
• W2090912504 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19236722" @default.
• W2090912504 hasPublicationYear "2009" @default.
• W2090912504 type Work @default.
• W2090912504 sameAs 2090912504 @default.
• W2090912504 citedByCount "80" @default.
• W2090912504 countsByYear W20909125042012 @default.
• W2090912504 countsByYear W20909125042013 @default.
• W2090912504 countsByYear W20909125042014 @default.
• W2090912504 countsByYear W20909125042015 @default.
• W2090912504 countsByYear W20909125042016 @default.
• W2090912504 countsByYear W20909125042017 @default.
• W2090912504 countsByYear W20909125042018 @default.
• W2090912504 countsByYear W20909125042019 @default.
• W2090912504 countsByYear W20909125042020 @default.
• W2090912504 countsByYear W20909125042021 @default.
• W2090912504 countsByYear W20909125042022 @default.
• W2090912504 countsByYear W20909125042023 @default.
• W2090912504 crossrefType "journal-article" @default.
• W2090912504 hasAuthorship W2090912504A5008651904 @default.
• W2090912504 hasAuthorship W2090912504A5033050158 @default.
• W2090912504 hasAuthorship W2090912504A5038330393 @default.
• W2090912504 hasAuthorship W2090912504A5069216326 @default.
• W2090912504 hasBestOaLocation W20909125041 @default.
• W2090912504 hasConcept C125418893 @default.
• W2090912504 hasConcept C185592680 @default.
• W2090912504 hasConcept C203014093 @default.
• W2090912504 hasConcept C2776960273 @default.
• W2090912504 hasConcept C2777413986 @default.
• W2090912504 hasConcept C2777583451 @default.
• W2090912504 hasConcept C2778461978 @default.
• W2090912504 hasConcept C2778729363 @default.
• W2090912504 hasConcept C2779536868 @default.
• W2090912504 hasConcept C3019892230 @default.
• W2090912504 hasConcept C42362537 @default.
• W2090912504 hasConcept C502942594 @default.
• W2090912504 hasConcept C55493867 @default.
• W2090912504 hasConcept C62478195 @default.
• W2090912504 hasConcept C71240020 @default.
• W2090912504 hasConcept C86803240 @default.
• W2090912504 hasConcept C98274493 @default.
• W2090912504 hasConceptScore W2090912504C125418893 @default.

• next